Abstract
ASSESSMENT OF ANTI THROMBIN III LEVEL IN SUDANESE PATIENTS WITH CHRONIC LIVER DISEASES

Mawdda Abdel Rhman Mohmed Elhassan Ahmed* and Amira Ahmed Khalid Humeida

ABSTRACT

Background: The liver is an important organ that synthesizes coagulation factors, liver disease is associated with a complex hemostasis defect, in which platelets, coagulation, and fibrinolysis may all be affected. In patients with hepatic parenchymal disease, the loss of functional parenchyma, results in decreased synthesis of both coagulation factors and natural anticoagulant proteins. The levels of coagulation factors and natural anticoagulant proteins synthesized in the liver are valuable in diagnosis and treatment, as they reflect the degree of hepatocyte damage. Recently, many studies have reported that the plasma concentrations of natural anticoagulants, such as antithrombin III (AT III), are altered in chronic liver diseases (CLD). In addition, the changes in synthesis of AT III occur in liver tissue and are associated with the extent of chronic hepatitis and cirrhosis. This study aimed to assess AT III level among chronic liver disease Sudanese patients and correlating it’s correlation with age, gender, type and duration of disease among cases and controls. Materials and Methods: This was a prospective case-control hospital-based study conducted to assess AT. III level among CLD Sudanese patients. Seventy (70) CLD patients were recruited as cases, and 30 healthy people were recruited as control group. This study was conducted at Ibn sina hospital in Khartoum, Sudan from April to August 2017. All statistical analyses were performed by SPSS software version (20). Results: In this study, the decrease of AT III level among cases than controls was the most important findings. Mean level of AT III among cases was within the lower normal limit (80-110 g\dl); (81.83 g\dl), 19 (27.1%) of cases their AT. III was lower than 80 g/dl. It had positive correlation with S. Albumin (p=.000) and negative correlation with duration of disease (P=.037) and both T. Bilirubin and D. Bilirubin (P= .041), (P=.010), respectively. Conclusion: This study concluded that; there was a strong effect of CLD on AT III level in plasma and this effected was correlated with duration of CLD and both S. Albumin and Bilirubin.

Keywords: AT III level, chronic liver disease.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: JUNE ISSUE PUBLISHED

    JUNE 2024 Issue has been successfully launched on 1 JUNE 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT